Flying Increases Risk of IBD Flares

Published Online: Tuesday, July 10, 2012
Flying to high altitudes may increase the risk of inflammatory bowel disease (IBD) flares, according to research presented at the 2012 Digestive Disease Week.

Investigators, led by Stephan Vavricka, MD, chief of the division of gastroenterology and hepatology at Triemli Hospital in Zurich, studied 103 patients who were seen at several IBD clinics in Switzerland over a period of 1 year. Both groups were asked about their activities during the previous 4 weeks through retrospective questionnaires. Fifty-two recently relapsed IBD patients were matched with 51 IBD patients in remission and the 2 patient groups were controlled for factors such as age, smoking, sports activities, and recent antibiotic treatment. IBD patients with flares reported traveling to heights of at least 2000 meters (6562 feet) during the study period more frequently compared with patients in remission (40.4% versus 15.7%, respectively). When broken down by IBD type, Crohn’s disease patients were found to have a higher risk of flare than ulcerative colitis patients.

Prior evidence has shown that oxygen depletion, or hypoxia, induces elevated levels of circulating proinflammatory cytokines and serum C–reactive protein, but little is known about how this inflammatory response affects IBD. “We need to look more closely at how hypoxia may induce inflammation on a molecular level in the intestines,” Dr. Vavricka said.

To read more articles in this watch, click:
Western Diet Increases Prevalence of IBS
The Annual Cost of Defecation Disorders

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues